Works matching IS 00099236 AND DT 1996 AND VI 59 AND IP 5
Results: 15
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 550, doi. 10.1016/S0009-9236(96)90183-6
- By:
- Publication type:
- Article
Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 593, doi. 10.1016/S0009-9236(96)90188-5
- By:
- Publication type:
- Article
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 491, doi. 10.1016/S0009-9236(96)90177-0
- By:
- Publication type:
- Article
Disposition and first-pass metabolism of ethanol in humans: Is it gastric or hepatic and does it depend on gender?<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 503, doi. 10.1016/S0009-9236(96)90178-2
- By:
- Publication type:
- Article
A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: In vivo evidence for the involvement of CYP3A4 in alprazolam metabolism<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 514, doi. 10.1016/S0009-9236(96)90179-4
- By:
- Publication type:
- Article
Pharmacokinetics of abecarnil in patients with renal insufficiency<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 520, doi. 10.1016/S0009-9236(96)90180-0
- By:
- Publication type:
- Article
Hepatic drug clearance in patients with mild cystic fibrosis<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 529, doi. 10.1016/S0009-9236(96)90181-2
- By:
- Publication type:
- Article
Direct demonstration of small intestinal secretion and site-dependent absorption of the β-blocker talinolol in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 541, doi. 10.1016/S0009-9236(96)90182-4
- By:
- Publication type:
- Article
New Members of the Society.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 595, doi. 10.1016/S0009-9236(96)90190-3
- Publication type:
- Article
Impaired β<sub>2</sub>-adrenergic agonist-induced venodilation in Indians of Asian origin<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 569, doi. 10.1016/S0009-9236(96)90185-X
- By:
- Publication type:
- Article
Direct angiotensin converting enzyme inhibitor-mediated venodilation<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 559, doi. 10.1016/S0009-9236(96)90184-8
- By:
- Publication type:
- Article
Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: Comparison of sparteine and dextromethorphan<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 583, doi. 10.1016/S0009-9236(96)90187-3
- By:
- Publication type:
- Article
List no. 382: New names.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 599, doi. 10.1016/S0009-9236(96)90191-5
- Publication type:
- Article
Introducing medical students to medication noncompliance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 577, doi. 10.1016/S0009-9236(96)90186-1
- By:
- Publication type:
- Article
A message from the Membership Committee chairman.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 5, p. 595, doi. 10.1016/S0009-9236(96)90189-7
- By:
- Publication type:
- Article